Evidence by drug
Metronomic methotrexate
101 studies and 20 trials indexed. 3 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingPhase 2United StatesNCT06997068Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationMayo Clinic
- RecruitingPhase 2United StatesNCT06085742BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerUniversity of Illinois Chicago
- Not yet recruitingPhase 2EgyptNCT07361133Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNational Cancer Institute, Egypt
Newest studies
- Phase 3 trialJCO Glob Oncol2026 JunIntegrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).Kapoor A, et al.
- StudyIndian J Surg Oncol2026 AprEfficacy of Metronomic Oral Capecitabine, Methotrexate and Cyclophosphamide in Locally Advanced Operable Oral Cavity Squamous Cell Carcinoma - A Phase II Study.Chanda S, et al.
- StudyCureus2026 MarLow-Dose Metronomic Chemotherapy With Fixed Low-Dose Nivolumab for Recurrent Cervical Cancer After Radiotherapy: Experience From Routine Clinical Practice.Ramidi GR, et al.
- StudyLancet Reg Health Southeast Asia2026 AprLow-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial.Marimuthu PK, et al.
- StudyOncol Res Treat2026Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic.Krajnak S, et al.
- StudyCureus2025 OctA Comparative Assessment of the Efficacy and Toxicity Profiles of Dual and Triple Oral Metronomic Chemotherapy in Advanced Head and Neck Cancers in a Tertiary Care Center.Nair RP, et al.
- StudyCancer Chemother Pharmacol2025 Oct 4Modulation of prostaglandin-endoperoxide synthase-2 (PTGS2) mediated VEGF-signalling pathway by oral metronomic chemotherapy in locally advanced oral squamous cell Carcinoma: A brief report.Kamal MV, et al.
- StudyClin Breast Cancer2025 JunOptimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.Trapani D, et al.
- Phase 3 trialJCO Glob Oncol2025 MayTriple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study).Kapoor A, et al.
- Case reportJ Neonatal Perinatal Med2025 MarInfantile myofibromatosis: Small bumps pose big problems.Lee HC, et al.
- StudyJCO Glob Oncol2024 MayEvaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.Bajpai J, et al.
- StudyEur J Cancer2024 MarMultiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.Rusakiewicz S, et al.
- Randomized trialBreast Cancer Res Treat2024 FebA randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.Mayer EL, et al.
- ReviewCureus2023 DecMetronomic Chemotherapy in Oral Cancer: A Review.Sethuraman S and Ramalingam K
- StudyClin Cancer Res2023 Dec 1Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.Joaquin Garcia A, et al.
- Case reportCureus2023 SepMetastatic Leptomeningeal Carcinomatosis From Primary Lobular Breast Cancer Found in a Medical School Cadaveric Dissection.Mitchell MC, et al.
- StudyBreast Care (Basel)2023 MayReal-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study.Krajnak S, et al.
- StudyLancet Reg Health Southeast Asia2023 MayLong term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer.Babanrao Dhumal S, et al.
- StudyLancet Reg Health Southeast Asia2023 MayMetronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation - a randomised trial.Patil V, et al.
- ReviewCancer Invest2023 FebA Mechanistic Review of Methotrexate and Celecoxib as a Potential Metronomic Chemotherapy for Oral Squamous Cell Carcinoma.Kamal MV, et al.
- Randomized trialJ Clin Oncol2023 Jan 10Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.Patil VM, et al.
- Randomized trialEsophagus2022 OctOral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial.Noronha V, et al.
- StudyGulf J Oncolog2022 SepMetronomic Therapy in Palliation of Oral Cancer Patients-A Home Based Approach at the End of Life.Sultania M, et al.
- StudyEcancermedicalscience2022Oral metronomic chemotherapy as a feasible preoperative therapy in advanced resectable oral cavity squamous cell carcinomas- a preliminary experience.Shenoy VPPK, et al.
- Phase 3 trialNat Commun2022 May 12CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer.Filippone MG, et al.
- Randomized trialOral Oncol2022 MayRMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.Patil V, et al.
- StudyClin Breast Cancer2022 AprA Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.Jung L, et al.
- ReviewFront Oncol2022Durable Effect of Pyrotinib and Metronomic Vinorelbine in HER2-Positive Breast Cancer With Leptomeningeal Disease: A Case Report and Literature Review.Chi Y, et al.
- ReviewOncol Res Treat2022Metronomic Chemotherapy for Metastatic Breast Cancer.Krajnak S, et al.
- StudyHead Neck2022 JanRole of metronomic therapy for advanced oral cancers and predictors of response: Multi-institutional feasibility study.Sultania M, et al.
- StudyEcancermedicalscience2021Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC).Kashyap L, et al.
- StudyBreast Cancer Res Treat2021 DecMetronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.Cazzaniga ME, et al.
- StudyJ Drug Target2021 DecA molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.Kina S, et al.
- StudyBreast2021 OctAdjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis.Bianco N, et al.
- StudyRambam Maimonides Med J2021 Jul 20Fibromatoses of Head and Neck: Case Series and Literature Review.Bhati M, et al.
- StudyIndian J Surg Oncol2021 MarLow Cost, Low Dose, Oral, Neoadjuvant Chemotherapy Protocol in Locally Advanced Borderline Oral Cancers-Feasibility Study.Sultania M, et al.
- CommentaryOral Oncol2021 MarMetronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic.Imaduddin M, et al.
- Phase 3 trialLancet Glob Health2020 SepLow-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.Patil V, et al.
- StudyBreast Cancer Res Treat2020 JulLow-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer-results of an exploratory case-control study.Krajnak S, et al.
- ReviewOral Oncol2020 JunBeyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity.Patil VM, et al.
